Africa Rapid Diagnostic Tests (RDT) Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Dec 2021
  • Country Level
  • 350 Pages
  • No of Tables: 155
  • No of Figures: 65

Africa Rapid Diagnostic Tests (RDT) Market, By Product Type (Consumables and Kits, Instruments and Others), Mode (Professional Rapid Diagnostic Test Product and Over-The-Counter [OTC] Rapid Diagnostic Test Product), Technology (PCR-Based, Flow-Through Assays, Lateral Flow Immunochromatographic Assays, Agglutination Assay, Microfluidics, Substrate Technology and Others), Modality (Laboratory Based Test and Non-Laboratory Based Test), Age Group (Adult and Pediatric), Test Type (Determining Confirmation, Serological Testing and Viral Sequencing), Approach (In-Vitro Diagnostic, Molecular Diagnostic), Specimen (Swab, Blood, Urine, Saliva, Sputum and Others), Application (Infectious Disease Testing, Glucose Monitoring, Cardiology Testing, Oncology Testing, Cardiometabolic Testing, Drugs-of-Abuse Testing, Pregnancy & Fertility Testing, Toxicology Testing, Others), End User (Hospital & Clinic, Diagnostic Laboratory, Home Care Setting, Research and Academic Institutes and Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (South Africa, Nigeria, Ethiopia and Rest of Africa), Industry Trends and Forecast to 2029  

Market Analysis and Insights: Africa Rapid Diagnostic Tests (RDT) Market

Africa rapid diagnostic tests (RDT) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.0% in the forecast period of 2022 to 2029 and is expected to reach USD 1,950.24 million by 2029 from USD  1,189.27 million in 2021. The rise in incidence in chronic diseases and technological advancements in rapid diagnostic tests are likely to be the major drivers which propel the demand of the market in the forecast period.

The rapid diagnostic tests, also called rapid tests, are easy-to-use tests that offer quick results, usually in less than 20 minutes. Unlike other standard and conventional tests, where the diagnosis and sampling are sent to the laboratory, the results obtained from rapid diagnostic test kits are provided at the point of care. The point of care is a place where the patients get cured. The point of care can be a provider's office, a clinic, or a patient's own house.

The RDTs are applicable for diagnosing and testing infectious diseases such as COVID-19, cardiology diseases, oncology, pregnancy, fertility testing, toxicology testing, drugs-of-abuse testing, cardiometabolic testing, and glucose monitoring.

The factors expected to drive the Africa rapid diagnostic tests (RDT) market are the increase in incidence in chronic diseases, rise in geriatric population, technological developments in the rapid diagnostic tests. However, the factors which are expected to restrain the market are the rise in the cost of rapid diagnostics, product recalls faced in rapid diagnostic tests, and lack of awareness about the use of rapid diagnostics. Moreover, the strategic initiatives by market players and the rise in healthcare expenditure are expected to create opportunities for the Africa rapid diagnostic tests (RDT) market growth. However, the need for skilled labor for sample collection and the late approval associated with product launches may significantly challenge market growth.

The Africa rapid diagnostic tests (RDT) market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Africa Rapid Diagnostic Tests (RDT) Market Africa Rapid Diagnostic Tests Market Scope and Market Size

The Africa rapid diagnostic tests (RDT) market is categorized into eleven notable segments based on product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the Africa rapid diagnostic tests (RDT) market is segmented into consumables and kits, instruments, and others. In 2022, the consumables and kits segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the availability of test kits at all times.
  • On the basis of mode, the Africa rapid diagnostic tests (RDT) market is segmented into professional rapid diagnostic test product, and over-the-counter [OTC] rapid diagnostic test (RDT) product. In 2022, the professional rapid diagnostic test product segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the increased use of products at healthcare facilities in Africa.
  • On the basis of technology, the Africa rapid diagnostic tests (RDT) market is segmented into PCR-based, flow-through assays, lateral flow immunochromatographic assays, agglutination assay, microfluidics, substrate technology, and others. In 2022, the PCR-based segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to reliability and delivery of results at a faster rate.
  • On the basis of modality, the Africa rapid diagnostic tests (RDT) market is segmented into laboratory based test and non-laboratory based test. In 2022, the laboratory based test segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the upcoming laboratory infrastructure in Africa.
  • On the basis of age group, the Africa rapid diagnostic tests (RDT) market is segmented into adult and pediatric. In 2022, the adult segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the surge in the geriatric population and chronic infectious diseases.
  • On the basis of test type, the Africa rapid diagnostic tests (RDT) market is segmented into determining confirmation, serological testing, and viral sequencing. In 2022, the determining confirmation segment is expected to dominate the Africa rapid diagnostic tests (RDT) market since it is crucial to determine the cause of infectious diseases and as the diagnosis by the RDTs provides accurate results of the diagnosis of infectious disease.
  • On the basis of approach, the Africa rapid diagnostic tests (RDT) market is segmented into in-vitro diagnostic and molecular diagnostic. In 2022, the in-vitro diagnostic segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to its ability to detect infectious diseases and detection of pregnancy and fertility disorders and its applicability in precision medicine.
  • On the basis of specimen, the Africa rapid diagnostic tests (RDT) market is segmented into swab, blood, urine, saliva, sputum, and others. In 2022, the swab segment is expected to dominate the Africa rapid diagnostic tests (RDT) market, due to its increased preference by the patients and advancements in serology, for the collection of swabs.
  • On the basis of application, the Africa rapid diagnostic tests (RDT) market is segmented into infectious disease testing, glucose monitoring, cardiology testing, oncology testing, cardiometabolic testing, drugs-of-abuse testing, pregnancy & fertility testing, toxicology testing, and others. In 2022, the infectious disease testing segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the rise in cases of chronic infectious disease in rural areas in Africa and government funding for the use of rapid diagnostics.
  • On the basis of end user, the Africa rapid diagnostic tests (RDT) market is segmented into hospital & clinic, diagnostic laboratory, home care setting, research and academic institutes, and others. In 2022, the hospital and clinic segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the availability of RDT kits in hospitals and clinics in Africa.
  • On the basis of distribution channel, the Africa rapid diagnostic tests (RDT) market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the Africa rapid diagnostic tests (RDT) market due to the equity in the tendering process.

Africa Rapid Diagnostic Tests Market Country Level Analysis

The Africa rapid diagnostic tests (RDT) market is analyzed, and market size information is provided by country, product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Growth Potential for Rapid Diagnostic Tests (RDT) in Emerging Economies and Strategic Initiatives by Market Players Create New Opportunities in the Africa Rapid Diagnostic Tests (RDT) Market 

The Africa rapid diagnostic tests (RDT) market also provides you with detailed market analysis for every country's growth in a particular industry with medical device outsourcing sales, the impact of advancement in the medical device outsourcing, and changes in regulatory scenarios with their support for the medical device outsourcing market. The data is available for the historical period 2011 to 2020.

Competitive Landscape and Africa Rapid Diagnostic Tests Market Share Analysis

The Africa rapid diagnostic tests (RDT) market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus on the medical device outsourcing market.

Some of the major companies in the Africa rapid diagnostic tests (RDT) market are BD, Abbott, Danaher, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, InBios International, Inc., Gnomegen LLC, QIAGEN, Quidel Corporation, Chembio Diagnostics Systems, Inc., Sekisui Diagnostics, PTS Diagnostics, Werfen, Nova Biomedical, Trinity Biotech, Luminex Corporation. A DiaSorin Company, Cardinal Health, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players and new technological advancements for rapid diagnostic tests (RDT) are bridging the gap for diagnosis and treatment.

For instance,

  • In December 2020, Quidel Corporation had received emergency approval, from the Food and Drug Administration (FDA), for the Quickvue Sars Rapid Antigen Test for the diagnosis of COVID-19. The approval resulted in increasing Quickvue Sars Rapid Antigen Test distribution to the medical and point-of-care locations and post-marketing approval
  • In June 2020, BD acquired Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease. This helped the company diversify its segments and revenue

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the Africa rapid diagnostic tests (RDT) market, which also benefits the organization to improve their offering for treatment products.  

Customization Available: Africa Rapid Diagnostic Tests (RDT) Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.  


SKU-

TABLE 1 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 AFRICA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 AFRICA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 AFRICA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 AFRICA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 AFRICA RT/PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 7 AFRICA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 AFRICA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 AFRICA OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 11 AFRICA PROFESSIONAL IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 AFRICA OVER-THE-COUNTER [OTC] IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 14 AFRICA PCR-BASED IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 AFRICA FLOW-THROUGH ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 AFRICA LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAYS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 AFRICA AGGLUTINATION ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 AFRICA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 AFRICA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 20 AFRICA SUBSTRATE TECHNOLOGY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 AFRICA OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 23 AFRICA LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 AFRICA NON-LABORATORY BASED TEST IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 26 AFRICA ADULT IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 AFRICA PEDIATRIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 29 AFRICA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 AFRICA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 31 AFRICA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 AFRICA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 33 AFRICA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 AFRICA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 35 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 36 AFRICA IN-VITRO DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 AFRICA MOLECULAR DIAGNOSTIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 39 AFRICA SWAB IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 AFRICA BLOOD IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 AFRICA URINE IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 AFRICA SALIVA IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 AFRICA SPUTUM IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 AFRICA OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 46 AFRICA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 AFRICA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 AFRICA GLUCOSE MONITORING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 AFRICA CARDIOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 AFRICA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 AFRICA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 52 AFRICA CARDIOMETABOLIC TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 AFRICA DRUGS-OF-ABUSE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 54 AFRICA PREGNANCY & FERTILITY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 AFRICA TOXICOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 AFRICA OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 58 AFRICA HOSPITAL & CLINIC IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 59 AFRICA DIAGNOSTIC LABORATORY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 60 AFRICA HOME CARE SETTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 61 AFRICA RESEARCH AND ACADEMIC INSTITUTES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 62 AFRICA OTHERS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 63 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 64 AFRICA DIRECT TENDER IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 65 AFRICA RETAIL SALES IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 66 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 67 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 68 AFRICA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 69 AFRICA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 70 AFRICA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 71 AFRICA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 72 AFRICA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 73 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 74 AFRICA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 75 AFRICA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 76 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 77 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 78 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 79 AFRICA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 80 AFRICA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 81 AFRICA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 82 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 83 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 84 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 AFRICA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 AFRICA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 88 AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 89 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 90 SOUTH AFRICA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 91 SOUTH AFRICA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 92 SOUTH AFRICA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 93 SOUTH AFRICA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 94 SOUTH AFRICA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 95 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 96 SOUTH AFRICA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 97 SOUTH AFRICA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 98 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 99 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 100 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 101 SOUTH AFRICA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 102 SOUTH AFRICA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 103 SOUTH AFRICA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 104 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 105 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 106 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 SOUTH AFRICA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 SOUTH AFRICA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 110 SOUTH AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 111 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 112 NIGERIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 113 NIGERIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 114 NIGERIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 115 NIGERIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 116 NIGERIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 117 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 118 NIGERIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 119 NIGERIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 120 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 121 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 122 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 123 NIGERIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 124 NIGERIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 125 NIGERIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 126 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 127 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 128 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 NIGERIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 NIGERIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 132 NIGERIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 133 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 134 ETHIOPIA CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 135 ETHIOPIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 136 ETHIOPIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 137 ETHIOPIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 138 ETHIOPIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 139 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2020-2029 (USD MILLION)

TABLE 140 ETHIOPIA LIQUID IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 141 ETHIOPIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 142 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2020-2029 (USD MILLION)

TABLE 143 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 144 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 145 ETHIOPIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 146 ETHIOPIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 147 ETHIOPIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 148 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2020-2029 (USD MILLION)

TABLE 149 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2020-2029 (USD MILLION)

TABLE 150 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 ETHIOPIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 152 ETHIOPIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 153 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 154 ETHIOPIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 155 REST OF AFRICA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions